News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

Articles by Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer

ByThomas E. Delea, MSIA,Jonathan Karnon, MSc, PhD,Robert E. Smith, MD,Stephen R. D. Johnston, MD, PhD, FRCP,Jane Brandman, BPharm, MS,Jennifer C. Y. Sung, PharmD,Paul E. Goss, MD, PhD, FRCPC, FRCP(UK)

July 15th 2006

Latest Updated Articles

Cost-effectiveness of Extended Adjuvant Letrozole Therapy After 5 Years of Adjuvant Tamoxifen Therapy in Postmenopausal Women With Early-stage Breast Cancer
Published: July 15th 2006 | Updated:

Trending on AJMC

TrumpRx Launch Brings Savings—and Uncertainty

5 Things to Know About the Oral GLP-1 Era

Exploring Identity, Appearance Experiences Among Patients With Alopecia

Stroke Subtype Does Not Affect Efficacy of Asundexian for Second Stroke Prevention

New Multiple Myeloma Therapies Offer Hope for Potential Cure: Ameet Patel, MD

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.

Alt Text

Alt Text